Abbott Laboratories on Pace for Largest Percent Decrease Since October 2023 — Data Talk
Abbott Laboratories (ABT) is currently at $105.74, down $3.46 or 3.17%
--Would be lowest close since Dec. 8, 2023, when it closed at $104.51
--On pace for largest percent decrease since Oct. 11, 2023, when it fell 5.04%
--Currently down three of the past four days
--Down 6.96% month-to-date
--Down 3.93% year-to-date
--Down 25.25% from its all-time closing high of $141.46 on Dec. 27, 2021
--Down 5.83% from 52 weeks ago (April 19, 2023), when it closed at $112.29
--Down 12.58% from its 52-week closing high of $120.96 on March 8, 2024
--Up 17.25% from its 52-week closing low of $90.19 on Oct. 12, 2023
--Traded as low as $104.25; lowest intraday level since Dec. 11, 2023, when it hit $104.21
--Down 4.54% at today's intraday low; largest intraday percent decrease since March 15, 2024, when it fell as much as 5.54%
All data as of 10:38:45 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 17, 2024 10:55 ET (14:55 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom